Trexquant Investment LP Kronos Bio, Inc. Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.12 - $7.52 $143,526 - $345,935	-46,002 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$6.26 - $14.42 $287,972 - $663,348	46,002 New	46,002 $333,000
Q4 2021 Feb 14, 2022	SELL	$11.35 - $21.18 $112,387 - $209,724	-9,902 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$18.17 - $24.7 $179,919 - $244,579	9,902 New	9,902 $208,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $54.5M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.